The invention relates to tetrahydroquinolinone derivatives as well as their pharmaceutially acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.


< Techniques for applying, calibrating, and controlling nerve fiber stimulation

< System, system devices, and methods for regulating nutrient absorption and caloric intake

> Preventives/remedies for urinary disturbance

> Amide compounds as ion channel ligands and uses thereof

~ 00207